-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$35.00191.91% Upside
Zenas BioPharma, Inc. Frequently Asked Questions
-
What analysts cover Zenas BioPharma, Inc.?
Zenas BioPharma, Inc. has been rated by research analysts at Jefferies in the past 90 days.